AGEN SEC Filings: 8-K, 10-Q, S-3 & 424B – Agenus

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 11, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 16, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 11, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Agenus Reports Third Quarter 2026 Results, Highlights First Marketing Authorizations for BOT+BAL and Progress on Phase 3 ROBBIN Study

Nov 5, 2026

8-K

Agenus Inc. Enters Second Loan Modification Agreement with Ocean 1181 LLC

Aug 18, 2026

8-K

Agenus Inc. Grants Performance-Based Stock Options to CEO Garo H. Armen

Aug 12, 2026

8-K

Agenus Inc. Appoints Marco Tullio Marcucci to Board of Directors

Aug 11, 2026

8-K

Agenus Reports Q2 2026 Results and Accelerates Phase 3 ROBBIN Trial for MSS Colon Cancer

Aug 6, 2026

8-K

Oversubscribed $340 Million Private Placement to Fund Phase 3 Trial for Neoadjuvant Treatment in MSS Colon Cancer

Jul 13, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Aug 17, 2026

424B5

ATM

Aug 8, 2024

424B5

ATM | Amount sold to date: $272,200,000

Mar 1, 2022

424B5

Up to 30,000,000 Shares

Dec 19, 2018

424B5

Up to 20,000,000 Shares

May 11, 2018

424B5

11,000,000 Shares

May 21, 2015

Registrations

TYPE

HEADLINE

FILED AT

S-3

SHARE RESALE REGISTRATION

Sep 11, 2026

S-8

Agenus Inc. Amends 2015 Inducement Equity Plan to Increase Share Reserve

Sep 2, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 7, 2026

S-3

SHARE RESALE REGISTRATION

Aug 7, 2026

S-3

SHARE RESALE REGISTRATION

Jul 17, 2026

S-3ASR

SHARE RESALE REGISTRATION | Shares amount: 1,318,084

Dec 29, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 13, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 30, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 20, 2026

DEFR14A

Form DEFR14A - Revised definitive proxy soliciting materials

Jun 6, 2025

DEFR14A

Form DEFR14A - Revised definitive proxy soliciting materials

May 5, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 30, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Wright Timothy (Reporting)

Oct 2, 2026

HARRISON THOMAS L (Reporting)

Oct 2, 2026

Marcucci Marco Tullio (Reporting)

Sep 16, 2026

Marcucci Marco Tullio (Reporting)

Sep 15, 2026

S-3

Form S-3 - Registration statement under Securities Act of 1933

Sep 11, 2026

ARMEN GARO H (Reporting)

Aug 12, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Aug 17, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jul 28, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Jun 2, 2025

CORRESP

Form CORRESP - Correspondence

May 28, 2025

LETTER

Form UPLOAD - SEC-generated letter

May 15, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 19, 2024

Agenus Inc. AGEN · SEC Filings